Benefit of immunotherapy for advanced melanoma in two patients with xeroderma pigmentosum

• A.C. Rivas Segovia,
• G. Gargantini Rezze,
• C. Carrera,
• M. Potrony,
• J. Malvehy,
• R.M. Huertas,
• F. Aya,
• J. Mestres,
• S. Podlipnik,
• A.M. Arance,
• L. Alos,
• S. Puig

Affiliations

A.C. Rivas Segovia

Hospital Clínic, Dermatology Department, Barcelona, Spain

G. Gargantini Rezze

Hospital Clínic, Dermatology Department, Barcelona, Spain

C. Carrera

Hospital Clínic, Dermatology Department, Barcelona, Spain; University of Barcelona, Medicine Department, Barcelona, Spain; Instituto de Salud Carlos III, CIBER de enfermedades raras, Barcelona, Spain

M. Potrony

Instituto de Salud Carlos III, CIBER de enfermedades raras, Barcelona, Spain; Hospital Clínic, Biochemistry and Molecular Genetic Department, Barcelona, Spain

J. Malvehy

Hospital Clínic, Dermatology Department, Barcelona, Spain; Instituto de Salud Carlos III, CIBER de enfermedades raras, Barcelona, Spain

R.M. Huertas

Hospital Clínic, Oncology Department, Barcelona, Spain

F. Aya

Hospital Clínic, Oncology Department, Barcelona, Spain

J. Mestres

Hospital Clínic, Radiology Department, Barcelona, Spain

S. Podlipnik

Hospital Clínic, Dermatology Department, Barcelona, Spain

A.M. Arance

Hospital Clínic, Oncology Department, Barcelona, Spain

L. Alos

Hospital Clínic, Pathology Department, Barcelona, Spain

S. Puig

Hospital Clínic, Dermatology Department, Barcelona, Spain; University of Barcelona, Medicine Department, Barcelona, Spain; Instituto de Salud Carlos III, CIBER de enfermedades raras, Barcelona, Spain